Lab Reference Library / GDF-15 (Growth Differentiation Factor 15)
Longevity & Aging
GDF-15 (Growth Differentiation Factor 15)
GDF-15 · Growth Differentiation Factor 15 · MIC-1Reference range, optimal functional medicine levels, and why GDF-15 is one of the most powerful emerging longevity biomarkers, rising with mitochondrial stress, inflammation, and aging, and why it independently predicts cardiovascular mortality, cancer risk, and all-cause mortality better than most conventional markers.
Longevity MarkerMost Searched
Standard RangeBelow 1,200 pg/mL
FM OptimalBelow 600 pg/mL
High RiskAbove 1,800 pg/mL
Unitspg/mL
← Back to Lab Reference Library
Category: Longevity & Aging | Also known as: Growth Differentiation Factor 15, GDF-15, MIC-1
1. What This Test Measures
Growth Differentiation Factor 15 (GDF-15) is a stress-responsive cytokine produced when cells experience mitochondrial dysfunction, DNA damage, oxidative stress, inflammation, or hypoxia. It rises progressively with aging as cellular stress accumulates and has emerged as one of the most powerful longevity biomarkers identified, independently predicting all-cause mortality, cardiovascular death, cancer incidence, and frailty in large prospective studies. Unlike many inflammatory markers, GDF-15 integrates multiple upstream cellular stress signals into a single readout, making it a sensitive and specific measure of overall biological aging rate.
GDF-15 signals through the GFRAL receptor in the hindbrain, suppressing appetite and promoting weight loss. This explains why conditions producing high GDF-15 (advanced cancer, heart failure, severe mitochondrial disease) are associated with cachexia and anorexia. Metformin's weight-loss effects are now known to be substantially mediated through GDF-15 elevation via its mitochondrial stress pathway.
2. Optimal Range
| GDF-15 Level | Interpretation |
|---|---|
| Below 400 pg/mL | Excellent: minimal cellular stress and aging burden; lowest mortality risk |
| 400 to 600 pg/mL | Optimal: low cellular stress for adults under 65 |
| 600 to 1,200 pg/mL | Borderline: evaluate for cardiovascular disease, metabolic syndrome, or cancer risk |
| 1,200 to 1,800 pg/mL | Elevated: significantly elevated all-cause mortality risk; comprehensive evaluation |
| Above 1,800 pg/mL | High: very high risk; screen for cardiovascular disease, cancer, mitochondrial dysfunction |
GDF-15 rises substantially with age even in healthy individuals: levels of 600 to 1,200 pg/mL are common in adults above 70 in excellent health. Age-adjusted interpretation is important; being below the age-matched median is more clinically meaningful than comparing to population-wide cutoffs. Metformin users typically have GDF-15 elevated 50 to 100% above pre-metformin baseline as part of the drug's mechanism.
3. What GDF-15 Elevation Predicts
Cardiovascular
- Heart failure: GDF-15 is among the strongest independent predictors of heart failure mortality; rises with myocardial wall stress, neurohormonal activation, and cardiomyocyte injury
- Coronary artery disease: elevated GDF-15 predicts major cardiovascular events independent of troponin, BNP, and standard lipid risk factors
- Post-MI risk stratification: GDF-15 above 1,800 pg/mL after MI identifies patients with dramatically elevated reinfarction and mortality risk
- Atrial fibrillation: GDF-15 predicts incident AF and stroke in AF patients
Longevity and Cancer
- All-cause mortality: one of the most powerful predictors of all-cause mortality across multiple large population cohorts, outperforming many established risk markers
- Cancer: many cancers produce GDF-15 as a pro-tumorigenic immune evasion factor; elevated GDF-15 often precedes clinical cancer diagnosis and is associated with worse prognosis
- Frailty: GDF-15 elevation correlates with muscle wasting, functional decline, and frailty syndrome in older adults
- Mitochondrial disease: GDF-15 is dramatically elevated in primary mitochondrial disorders and is used as a diagnostic and monitoring marker
4. How to Lower GDF-15
Lifestyle
- Regular aerobic exercise: despite transiently raising GDF-15 during exertion, chronic training reduces resting GDF-15 through mitochondrial biogenesis and reduced oxidative stress burden
- Sleep optimization: sleep deprivation increases cellular stress and GDF-15; consistent 7 to 9 hours reduces chronic stress-driven GDF-15 production
- Weight loss targeting visceral fat: reduces metabolic and inflammatory cellular stress
- Stress management: chronic psychological stress activates cellular stress pathways driving GDF-15
Mitochondrial Support
- CoQ10 (ubiquinol, 200 to 400mg daily): reduces mitochondrial oxidative stress and electron transport chain dysfunction that produces GDF-15 stress signaling
- NAD+ precursors (NMN or NR, 250 to 500mg daily): restore mitochondrial NAD+ levels; mitochondrial dysfunction from NAD+ depletion is a primary GDF-15 driver
- Alpha-lipoic acid (600mg daily): mitochondrial antioxidant that reduces oxidative stress-driven GDF-15 production
- Magnesium: required for mitochondrial enzyme function; deficiency impairs mitochondrial ATP production and increases GDF-15
Anti-Inflammatory
- Mediterranean diet: reduces chronic inflammatory cellular stress driving GDF-15 production
- Omega-3 fatty acids (2 to 4g EPA and DHA daily): reduces neuroinflammatory and systemic inflammatory GDF-15 stimuli
- Treat underlying cardiovascular disease: the most impactful GDF-15 reduction intervention when cardiac disease is the primary driver
- Cancer screening and treatment: malignancy-driven GDF-15 elevation requires cancer identification and management
5. Related Lab Tests
KlothoLongevity Companion Marker; Both Reflect Aging Biology
→
NAD+NAD+ Depletion Drives Mitochondrial GDF-15 Production
→
Telomere LengthBiological Age Companion Assessment
→
hs-CRPSystemic Inflammatory Context for GDF-15
→
ApoBCardiovascular Risk Context for GDF-15 Elevation
→
IGF-1Growth Factor Context for Longevity Panel
→
6. Clinical Perspective
Clinical Perspective
GDF-15 is the longevity marker I am most excited about because it integrates what is happening at the mitochondrial level with what is happening at the cardiovascular and cancer risk level in a single number. My patients on metformin consistently have GDF-15 above their age-matched peers, and I explain to them that this is partially the mechanism of the drug, not a sign of harm. But when I see a patient with GDF-15 of 2,200 pg/mL who is not on metformin and has no obvious cardiac history, that is a different conversation: I want to know their cardiovascular status in detail, I want to screen for occult cancer, and I want to know their mitochondrial health. It is an integrative stress biomarker that asks the body: what is actually going wrong at the cellular level right now? And unlike many markers, it consistently answers with actionable information.
Brian Lamkin, DO | Founder, The Lamkin Clinic | Edmond, Oklahoma
7. Frequently Asked Questions
What is GDF-15 and why is it a longevity marker?
GDF-15 is a stress-responsive cytokine produced when cells experience mitochondrial dysfunction, DNA damage, oxidative stress, or inflammation. It rises progressively with aging as cellular stress accumulates. Multiple large prospective studies demonstrate that it independently predicts all-cause mortality, cardiovascular death, cancer incidence, and frailty better than many conventional markers, functioning as an integrative readout of biological aging rate.
What causes elevated GDF-15?
Elevated GDF-15 is produced by: aging and mitochondrial dysfunction, cardiovascular disease (particularly heart failure and post-MI), cancer, chronic kidney disease, obesity and insulin resistance, chronic inflammation, and metformin (which elevates GDF-15 through its mitochondrial stress pathway as part of its beneficial mechanism).
Does metformin raise GDF-15?
Yes. Metformin's weight-loss effects and some of its longevity effects are now known to be substantially mediated through GDF-15 elevation via mitochondrial stress pathway activation. Metformin users typically have GDF-15 levels 50 to 100% above their pre-metformin baseline. This metformin-induced GDF-15 elevation should not be interpreted as a disease signal in the context of intentional metformin therapy.
How do you lower GDF-15?
Strategies include: regular aerobic exercise, sleep optimization, weight loss targeting visceral fat, CoQ10 and NAD+ precursor supplementation to reduce mitochondrial stress, omega-3 fatty acids, Mediterranean diet, treating underlying cardiovascular disease (the most impactful intervention when cardiac disease is the primary driver), and cancer identification and treatment when malignancy drives elevation.
Content authored and clinically reviewed by Brian Lamkin, DO, founder of The Lamkin Clinic in Edmond, Oklahoma. Brian Lamkin, DO has 25+ years of experience in functional and regenerative medicine. This page reflects current functional medicine practice standards and is updated as new clinical evidence becomes available.
GDF-15 above 1,800 pg/mL without metformin is a biological distress signal from the mitochondria. It warrants comprehensive investigation.
GDF-15 is the longevity marker that reveals what is happening at the cellular stress level before disease becomes clinically apparent. Schedule a consultation for a complete longevity biomarker assessment.
Schedule a ConsultationMedical Disclaimer: This content is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Lab interpretation should always be performed in clinical context by a qualified healthcare provider. Reference ranges and optimal targets may vary based on individual patient history, clinical presentation, and laboratory methodology. Schedule a consultation to discuss your specific results with Dr. Lamkin.